&nbsp;

dapProstateJuly18.html

Jul 2018

Drug

ribociclib

Other Name(s): Kisqali™

Quick Link(s): Drug Monograph, Patient Info Sheet

Jan 2022

Regimen

DURV

Cancer Type:

Lung,

Non-Small Cell

Intent: Curative

Funding:

New Drug Funding Program

Durvalumab - Locally Advanced Unresectable Stage III Non-Small Cell Lung Cancer Following Concurrent Chemoradiation

, Collapse Show fewer tags

Drugs Used:

durvalumab

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2024

Document

Recommendation Report for Ontario’s Clinical Genetic Services

Oct 2018

Guidelines and Advice

Recommendation Report: Entry and Transfer of Care Criteria for Colorectal Diagnostic Assessment Programs (DAPs) in Ontario

Status: Education and Information
Version: 1

Mar 2018

Reimbursement Instructions – Case-by-Case Review Program

Radiation Treatment Capital Investment Strategy

Document

RiskFactorsForProstateCancer.jpg

Oct 2018

Regimen

DENO

Cancer Type:

Hematologic,

Multiple Myeloma

, Collapse Show fewer tags

Intent: Palliative

Drugs Used:

denosumab (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2024

Document

Dr. Debra Bournes

Nov 2018

Document

Defining_Advanced_Practice_in_Radiation_Therapy_A_feasibility_assessment_of_a_new_healthcare_provider_role_in_Ontario

Mar 2019

Regimen

DARA(MNT)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Daratumumab - In Combination with Bortezomib and Dexamethasone for Relapsed Multiple Myeloma

New Drug Funding Program

Daratumumab in Combination with a Bortezomib-Based Regimen for Newly Diagnosed Transplant Ineligible Multiple Myeloma